Higano, Celestia S <br/><br/>
Safety analysis of repeated high doses of samarium-153 lexidronam in men with hormone-naive prostate cancer metastatic to bone.  [electronic resource] 

 -  Clinical genitourinary cancer  Mar 2008 
 - 40-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1558-7673 
<br/><br/><label>Standard No.: </label>10.3816/CGC.2008.n.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Aged<br/>Aged, 80 and over<br/>Analgesics, Non-Narcotic--administration & dosage<br/>Bone Neoplasms--drug therapy<br/>Dose-Response Relationship, Drug<br/>Feasibility Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasms, Hormone-Dependent--pathology<br/>Organometallic Compounds--administration & dosage<br/>Organophosphorus Compounds--administration & dosage<br/>Prostatic Neoplasms--pathology<br/>Samarium<br/>Survival Rate